Pfenex Inc (AMEX:PFNX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - PFNX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - PFNX

  • Market Cap$437.280m
  • SymbolAMEX:PFNX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS7170711045

Company Profile

Pfenex Inc is a clinical-stage biotechnology company involved in the development of protein production and bioanalytic technology. The biosimilars portfolio include PF582, for the treatment of patients with retinal diseases; PF530, designed to treat patients with multiple sclerosis; and PF708, to treat osteoporosis patients at high risk of fractures. Its vaccine portfolio consists of Px563L, a novel anthrax vaccine candidate to meet U.S. government demand, funded by the U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority.Pfenex Inc is a clinical-stage biotechnology company. It is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and difficult-to-manufacture proteins.

Latest PFNX news

Currently there for this company. Visit our news hub for other news .